CHM 5.56% 1.9¢ chimeric therapeutics limited

Ann: Exclusive option exercised for CORE-NK platform, page-2

  1. 256 Posts.
    lightbulb Created with Sketch. 62
    Very happy to see this announcement. Trusting the management team to continue to develop the pipleline and looking forward to updates from the clinic.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.